Research Axis
Immune Diseases and Cancer Axis
Research Theme
Immune diseases: mechanisms, new therapeutic approaches and disease outcomes
Address
CHUSJ - Centre de Recherche
Phone
514 345-4931 #4713
Fax
514 345-4897
Career Summary
Dr. Elie Haddad specializes in clinical and basic research in pediatric immunology. After completing his medical training in pediatric immunology and hematopoietic stem cell transplantation with Dr. Alain Fischer in Paris, he obtained his PhD in fundamental immunology (Villejuif, France) and then undertook postdoctoral work in immunonephrology at Hôpital Bichat (Paris, France).
In 2005, he was recruited by CHU Sainte-Justine as a physician-scientist and the head of the Immuno-Allergy and Rheumatology Division. Dr. Haddad is Professor of Pediatrics at the University of Montreal, Canada, and he is the Head of the Research Axis “Immune Diseases and Cancer” at CHU Sainte-Justine Research Centre.
The major activity of his clinical research is focused on primary immune deficiency and as a recognized international expert on this field, he is an elected councilor of the Clinical Immunology Society (CIS). He is one of the three PI of the Primary Immune Deficiency Treatment Consortium, a NIH-funded consortium of 47 North-American Centers. He is also one of the Faculty of the CIS summer school.
The major activity of his fundamental research is on cancer immunotherapy, mostly on the field of NK-cell and stem-cell based cellular therapy. Dr. Haddad has also set up a humanized mice platform to develop relevant and innovative preclinical models of cancer immunotherapy and study of immunopathology.
Dr. Haddad has published more than 160 manuscripts in both clinical and basic research and his research has been funded by the Canadian Cancer Society, the Canadian Institutes for Health Research, the Canadian Fund for Innovation, the Natural Sciences and Engineering Research Council of Canada, the Fonds de recherche du Québec - Santé, and the National Institute of Health (US).